HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Sanofi

This article was originally published in The Rose Sheet

Executive Summary

Sanofi: Beauty sales increased 4.3% to $649.7 mil. (3.96 bil. FFr) for 1997. Boosted by the introduction of the women's scent So, Oscar de la Renta sales grew 40%, the company reported. Yves Saint Laurent sales, however, remained flat "in the absence of a fragrance launch" during the year. The smaller fragrance businesses, Van Cleef & Arpels, Roger & Gallet and Krizia/Fendi, all posted sales increases for the 12 months. In North America, sales slipped due to the flat fragrance market "situation in major U.S. department stores." European sales (excluding France) increased for the year, while sales in Southeast Asia were down. Yves Rocher saw a 3% sales increase during the year to $1.31 bil. (8 bil. FFr). Sanofi owns a controlling interest in the catalog and mass marketer. The company sold its other partially owned business, Nina Ricci, to Antonio Puig, S.A. on Jan. 8 ("The Rose Sheet" Dec. 22, 1997, In Brief). Consolidated sales for the year grew 8.6% to $4.21 bil. In the face of rumors to the contrary, Sanofi continues to deny its beauty business is for sale...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS005123

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel